Incident Stroke Tied to Acute, Accelerated Long-Term Cognitive Decline
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 3, 2024 -- For older stroke survivors, incident stroke is associated with acute and accelerated long-term cognitive decline, according to a study published online Oct. 2 in JAMA Network Open.
Jessica W. Lo, from the University of New South Wales in Sydney, and colleagues mapped the trajectory of cognitive function before and after stroke in global cognition and in four cognitive domains in a study using harmonized and pooled data from 14 population-based cohort studies. The analyses included 20,860 participants (mean age, 72.9 years) who were followed for 7.51 years.
The researchers observed an association between incident stroke and a substantial acute decline in global cognition (−0.25 standard deviation [SD]), the Mini-Mental State Examination, and all cognitive domains (ranging from −0.17 to −0.22 SD) relative to a stroke-free cognitive trajectory. In addition, there was accelerated decline in global cognition (−0.038 SD per year) and all domains except memory (ranging from −0.020 to −0.055 SD per year). Compared with the rate of decline in individuals without stroke, no significant difference in prestroke slope was seen in stroke survivors in all cognitive measures. In global cognition, the mean rate of decline without a previous stroke was −0.049 SD per year.
"Targeting modifiable vascular risk factors at an early stage may reduce the risk of stroke but also subsequent risk of stroke-related cognitive decline and cognitive impairment," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-04 12:00
Read more
- New Alzheimer's prevention trial receives $74.5 million NIH grant
- Prevalence of High Total Cholesterol 11.3 Percent in U.S. Adults
- FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea
- First U.S. Case of New Mpox Strain Spotted in Traveler
- 1 in 4 Americans Now Struggling to Cover Medical Costs
- Poll Finds Many Parents Struggling to Manage Kids' Anger
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions